Category: Equity: Sectoral-Pharma and Healthcare |
Launch Date: 10-07-2018 |
Asset Class: Equity |
Benchmark: S&P BSE Healthcare TRI |
TER: 2.05974208% As on (30-09-2023) |
Status: Open Ended Schemes |
Minimum Investment: 5000.0 |
Minimum Topup: 1000.0 |
Total Assets: 1,783.19 Cr As on (31-10-2023) |
Turn over: - | Exit Load: Exit load of 1% if redeemed within 1 year. |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
Standard Deviation | 16.02 |
Sharpe Ratio | 0.7 |
Alpha | 0.88 |
Beta | 0.97 |
Yield to Maturity | - |
Average Maturity | - |
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Small Cap
13.21%
Others
8.69%
Large Cap
48.88%
Mid Cap
29.22%
Long term capital gains (LTCG) tax @10% (plus surcharge, if applicable and cess) without indexation if units held for more than 12 months#
Short term capital gains (STCG) tax @ 15% (plus surcharge, if applicable and cess) if units are held for less than 12 months.
Investor does not pay any tax on dividends but a Dividend Distribution Tax (DDT) is deducted at source @11.648% (10% + 12% surcharge + 4% Health & education cess) **
# Capital gain accrued up to January 31st 2018 is exempt from LTCG tax in respect of units acquired before January 31, 2018 & redeemed on or after April 1, 2018. ** The DDT is to be paid by the mutual fund